|
2023
|
Invention
|
Process for preparing glucagon-like peptide-1. The present disclosure provides an improved proces... |
|
|
Invention
|
Process for preparing glucagon-like peptide-1.
The present disclosure provides an improved proce... |
|
|
Invention
|
Process for preparing relugolix and intermediates thereof.
The present disclosure provides impro... |
|
|
Invention
|
Process for preparing relugolix and intermediates thereof. The present disclosure provides improv... |
|
2022
|
G/S
|
Injection devices for pharmaceuticals; needles for medical use and medical syringes |
|
|
Invention
|
Process for preparing cedazuridine. A one-pot process for preparing cedazuridine of formula (I), ... |
|
|
Invention
|
Process for preparing cedazuridine.
A one-pot process for preparing cedazuridine of formula (I),... |
|
|
Invention
|
Drug-loaded mesoporous silica nanoparticle for prevention and treatment of brain cancers or brain... |
|
2021
|
Invention
|
Improved process for preparing osimertinib or a salt thereof. Provided herein are improved proces... |
|
|
Invention
|
A novel crystalline form of ivacaftor and a process for preparing the same. In certain aspects, t... |
|
|
Invention
|
Crystalline form of ivacaftor and a process for preparing the same. In certain aspects, the inven... |
|
|
Invention
|
Process for purifying semaglutide and liraglutide.
The present invention provides improved proce... |
|
2020
|
Invention
|
Process for preparing osimertinib or a salt thereof. Provided herein are improved processes and m... |
|
|
Invention
|
Process for preparing elagolix sodium and intermediates thereof. NN-benzylidene protected compoun... |
|
|
Invention
|
Process for preparing elagolix sodium and intermediates thereof. The present invention provides i... |
|
|
Invention
|
A novel crystalline form of olaparib and a process for preparing the same. HH)phthalazin-1-one). ... |
|
|
Invention
|
Polymorphism for irinotecan free base. Crystalline form S1 of irinotecan free base characterized ... |
|
|
Invention
|
Process for purifying liraglutide. The present invention provides improved processes for purifyin... |
|
2019
|
Invention
|
Analyzing high dimensional data based on hypothesis testing for assessing the similarity between ... |
|
|
Invention
|
Crystalline form of olaparib and a process for preparing the same. In certain aspects, the invent... |
|
|
Invention
|
Crystal forms of lifitegrast. Crystalline form S1 of lifitegrast characterized by a powder X-ray ... |
|
2018
|
Invention
|
Method for preparing sugammadex sodium. A process for preparing sugammadex sodium comprising: rea... |
|
|
Invention
|
Method for preparing sugammadex sodium.
A process for preparing sugammadex sodium comprising:
... |
|
|
Invention
|
Process for preparing lifitegrast and intermediates thereof. The present disclosure provides effi... |
|
|
Invention
|
Process for preparing aripiprazole lauroxil and intermediates thereof. A process for preparing a ... |
|
|
Invention
|
Process for preparation of cangrelor tetrasodium and intermediate therefor. A process for prepari... |
|
|
Invention
|
Process for preparing aripiprazole lauroxil and intermediates thereof.
A process for preparing a... |
|
|
Invention
|
Process for preparation of cangrelor tetrasodium and intermediate therefor.
A process for prepar... |
|
|
Invention
|
Method for preparing sugammadex sodium. reacting the compound of formula II with 3-mercapto propi... |
|
|
Invention
|
Process for preparing apalutamide. The present invention provides efficient, economical, and envi... |
|
|
Invention
|
Process for preparing apalutamide.
The present invention provides efficient, economical, and env... |
|
|
Invention
|
Process for preparing ixazomib citrate and intermediates therefor. A process for making ixazomib ... |
|
2017
|
Invention
|
Crystalline forms of olaparib and manufacturing processes therefor. In certain aspects, the inven... |
|
|
Invention
|
Processes for preparing olaparib. Provided herein are novel processes and methods for making 4-[(... |
|
|
Invention
|
Process for preparing ataluren and its intermediates. The present invention provides processes fo... |
|
|
Invention
|
Process of preparing amorphous form of idelalisib.
A process for preparing an amorphous form of ... |
|
|
Invention
|
Process for preparing sglt2 inhibitors and intermediates thereof. The present invention provides ... |
|
|
Invention
|
Crystalline forms of olaparib and manufacturing processes therefor.
In certain aspects, the inve... |
|
2016
|
Invention
|
Process for preparing ibrutinib and its intermediates. The present invention provides efficient, ... |
|
|
Invention
|
Crystalline forms of pemetrexed diacid and manufacturing processes therefor. Crystalline forms of... |
|
2013
|
G/S
|
Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations; m... |
|
|
G/S
|
Active pharmaceutical ingredients sold as integral components of pharmaceutical reparations for h... |
|
|
G/S
|
Active pharmaceutical ingredients sold as integral components of pharmaceutical preparations for ... |
|
2011
|
G/S
|
Active pharmaceutical ingredients for medicine; medicines for use in human; nutritional additives... |
|
2010
|
G/S
|
Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations, n... |
|
2009
|
G/S
|
Chemical research, chemical analysis, biological [ research, biological research and ] analysis, ... |
|
|
G/S
|
Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations an... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
1998
|
G/S
|
Active pharmaceutical ingredients sold as an integral component of pharmaceutical preparations fo... |
